Specific features of ß-catenin-mutated hepatocellular carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Hepatology

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer death.
• The Wnt/ß-catenin pathway, regulated by the CTNNB1 gene, is frequently altered in HCC.
• CTNNB1 mutations define a distinct subclass of HCC.

Purpose of the Study:

• To review recent advances in classifying CTNNB1-mutated HCC.
• To elucidate mechanisms of ß-catenin regulation and function.
• To discuss therapeutic strategies for CTNNB1-mutated liver tumors.

Main Methods:

• Literature review focusing on CTNNB1 gene mutations in HCC.
• Analysis of gene expression patterns and phenotypic characteristics.
• Examination of regulatory mechanisms of ß-catenin.

Main Results:

• CTNNB1-mutated HCC exhibits unique features: well-differentiated cells, low proliferation, cholestasis, metabolic changes, immune exclusion, and invasion.
• Specific gene expression patterns characterize this HCC subclass.
• Aberrant ß-catenin stabilization and transcriptional activity are key.

Conclusions:

• CTNNB1-mutated HCC represents a distinct clinicopathological and molecular subclass.
• Understanding these features is crucial for targeted therapy development.
• Targeting ß-catenin offers therapeutic potential for liver tumors.